Cumberland Pharmaceuticals (CPIX) EBIT Margin (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported EBIT Margin of 34.27% for Q1 2026, down 4530.0% on a YoY basis from 0.77% in Q1 2025, and down 241.86% sequentially from 10.02% in Q4 2025.
Cumberland Pharmaceuticals (CPIX) EBIT Margin (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of EBIT Margin data on file, last reported at 34.27% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 4530.0% year-over-year to 34.27%; the trailing twelve-month figure through Mar 2026 stood at 17.2% (down 924.0% YoY), and the FY2025 full-year result was 6.27%, up 1072.0% from the prior year.
- EBIT Margin declined to 34.27% in Q1 2026, from 10.02% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 11.03% in Q1 2025 to a low of 66.07% in Q4 2023.
- A 5-year average of 17.09% and a median of 17.65% in 2024 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin jumped 4841 bps in 2024 and sank 4530 bps in 2026, its largest moves.
- Tracing CPIX's EBIT Margin over 5 years: stood at 24.97% in 2022, then plunged by 165 bps to 66.07% in 2023, then soared by 73 bps to 17.65% in 2024, then soared by 43 bps to 10.02% in 2025, then sank by 242 bps to 34.27% in 2026.
- Business Quant data shows CPIX's EBIT Margin at 34.27% in Q1 2026, 10.02% in Q4 2025, and 23.7% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | -34.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.27% |
| Dec 31, 2025 | -10.02% |
| Sep 30, 2025 | -23.70% |
| Jun 30, 2025 | -6.90% |
| Mar 31, 2025 | 11.03% |
| Dec 31, 2024 | -17.65% |
| Sep 30, 2024 | -18.65% |
| Jun 30, 2024 | -10.42% |
| Mar 31, 2024 | -22.00% |
| Dec 31, 2023 | -66.07% |
| Sep 30, 2023 | -18.51% |
| Jun 30, 2023 | 0.21% |
| Mar 31, 2023 | -16.60% |
| Dec 31, 2022 | -24.97% |
| Sep 30, 2022 | -2.53% |
| Jun 30, 2022 | -17.93% |
| Mar 31, 2022 | -11.56% |
| Dec 31, 2021 | -52.33% |
| Sep 30, 2021 | -19.37% |
| Jun 30, 2021 | -15.85% |